Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; "Ono"), today announced that data ...

Topline data from registrational trial in stiff person syndrome (SPS) now expected in early 2026; narrowed from previous guidance of first half 2026; BLA submission anticipated in 1H 2026 Positive ...

In this Q&A, Beowolff Capital CEO Andrew Wolff explains why he believes the future of the art market lies in transparency, data and A.I.-powered collaboration. He outlines how integrating ...

It has been 10 years since J.P. Morgan launched its annual e-Trading Edit, a comprehensive survey of trends and topics in the ...

Prime Unicorn 30 Index Is Up 54% through the End of Q3 2025 and Now Surpasses $1 Trillion in Total Market Value ...

Independent Investment Research updates developments in Australia's listed investment trust and provides comparative data ...

Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...

The last central public sector enterprise (CPSE) to launch an IPO in 2024, which was followed by the entry of state-run insurance behemoth LIC's shares in the country's listed spa ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first presentation of results from the pivotal Phase 3 CORALreef Lipids trial demonstrating that treatment ...

MCA invites bids to study Big Tech thresholds and core digital services under India’s Digital Competition Bill.

Getty had taken action against Stability AI, alleging that its generative model, Stable Diffusion, which produces ...

The number of tertiary international students studying in Malta has increased by over a quarter in just one year, new data ...